Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss–Newton method
Abstract The dipeptidyl peptidase‐4 (DPP‐4) inhibitor linagliptin (LNG) exhibits target‐mediated drug disposition (TMDD) in clinical settings, characterized by saturable binding to plasma soluble DPP‐4 (sDPP‐4) and tissue transmembrane DPP‐4 (tDPP‐4). Previous studies have indicated that saturable r...
Saved in:
| Main Authors: | Ryo Nakamura, Takashi Yoshikado, Yasunori Aoki, Yuichi Sugiyama, Koji Chiba |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012-06-01) -
Is the GFR‐based scaling approach adequate for predicting pediatric renal clearance of drugs with passive tubular reabsorption? Insights from PBPK modeling
by: Sanwang Li, et al.
Published: (2025-01-01) -
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma
by: Dongyuan Su, et al.
Published: (2025-07-01) -
Linagliptin-Induced Pancreatitis
by: Husam El Sharu, et al.
Published: (2023-10-01) -
Algoritmo metaheurístico GWO-GAUSS_NEWTON aplicado a problemas de localización
by: Alian Ernesto Matos Rodríguez, et al.
Published: (2023-02-01)